{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:57:00Z","timestamp":1793725020535,"version":"4.6.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"French Government"},{"name":"National Research Agency","award":["ANR-16-RHUS-0003"],"award-info":[{"award-number":["ANR-16-RHUS-0003"]}]},{"name":"GCS G4"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Transcatheter aortic valve replacement (TAVR) as an alternative to surgical aortic valve replacement (SAVR) has profoundly changed the management of patients with aortic valve stenosis (AS). Large unbiased nationwide data regarding TAVR implementation, impact on SAVR and their respective outcomes are scarce.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Based on a French administrative hospital-discharge database, we collected data on all consecutive aortic valve replacements (AVRs) performed in France for AS between 2007 and 2019 [106 253 isolated SAVR (49%), 46 514 combined SAVR (21%), and 65 651 TAVR (30%)]. The number of AVR linearly increased between 2007 and 2019 (from 10 892 to 23 109, P for trend &amp;lt; 0.0001) due to a marked increase in TAVR (from 253 to 13 030, P for trend &amp;lt; 0.0001), while SAVR increased up to 2013 and then declined (10 892 in 2007, 12 699 in 2013, and 10 079 in 2019). The Charlson index decreased linearly for TAVR, but in two steps for SAVR (2011 and 2017). In-hospital mortality rates of both SAVR and TAVR declined (both P for trend &amp;lt; 0.0001) and were similar or lower for TAVR than for isolated SAVR in patients 75 years or above in the last 3 years (2017\u201319). Complication rates of TAVR also declined but permanent pacemaker rates remained high and length of stay substantial (16.7% and median 6 days, respectively, in 2017\u201319).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The number of AVR has doubled in a decade and TAVR has become the dominant form of AVR in 2018. The improvement in patient profiles seems to have anticipated the demonstrated benefit of TAVR in intermediate and low-risk patients. In patients 75 years or older, TAVR should be considered as the first option. We also highlight two important areas for improvement, the high permanent pacemaker rates, and the long length of stay even in the contemporary era. Our results may have major implications for clinical practice and policymakers.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab773","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T19:13:31Z","timestamp":1635189211000},"page":"666-679","source":"Crossref","is-referenced-by-count":81,"title":["Trends in aortic valve replacement for aortic stenosis: a French nationwide study"],"prefix":"10.1093","volume":"43","author":[{"given":"Virginia","family":"Nguyen","sequence":"first","affiliation":[{"name":"Cardiology Department, Centre Cardiologique du Nord , Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4750-3425","authenticated-orcid":false,"given":"Nadav","family":"Willner","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Ottawa Heart Institute , Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Eltchaninoff","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Normandie University, UNIROUEN, U1096, CHU Rouen , Rouen, F-76000 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1083-2284","authenticated-orcid":false,"given":"Ian G","family":"Burwash","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Ottawa Heart Institute , Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6090-8211","authenticated-orcid":false,"given":"Morgane","family":"Michel","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris , Paris, France"},{"name":"URC Eco Ile de France, AP-HP , H\u00f4tel Dieu, Paris, France"},{"name":"INSERM, ECEVE, U1123 , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Durand","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Normandie University, UNIROUEN, U1096, CHU Rouen , Rouen, F-76000 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Gilard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Brest University Hospital , Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Dindorf","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Normandie University, UNIROUEN, U1096, CHU Rouen , Rouen, F-76000 France"},{"name":"Universit\u00e9 de Paris , Paris, France"},{"name":"URC Eco Ile de France, AP-HP , H\u00f4tel Dieu, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9127-348X","authenticated-orcid":false,"given":"Bernard","family":"Iung","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris , Paris, France"},{"name":"Department of Cardiology, Assistance Publique\u2014H\u00f4pitaux de Paris (AP-HP), Bichat Hospital , Paris, France"},{"name":"INSERM U1148, Bichat Hospital , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Cribier","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Normandie University, UNIROUEN, U1096, CHU Rouen , Rouen, F-76000 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9413-4891","authenticated-orcid":false,"given":"Alec","family":"Vahanian","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris , Paris, France"},{"name":"INSERM U1148, Bichat Hospital , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Chevreul","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Paris , Paris, France"},{"name":"URC Eco Ile de France, AP-HP , H\u00f4tel Dieu, Paris, France"},{"name":"INSERM, ECEVE, U1123 , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6278-5670","authenticated-orcid":false,"given":"David","family":"Messika-Zeitoun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Ottawa Heart Institute , Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"2022102517252562000_ehab773-B1","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease: the Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102517252562000_ehab773-B2","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2022102517252562000_ehab773-B3","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"key":"2022102517252562000_ehab773-B4","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"key":"2022102517252562000_ehab773-B5","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N Engl J Med"},{"key":"2022102517252562000_ehab773-B6","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","article-title":"5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Kapadia","year":"2015","journal-title":"Lancet"},{"key":"2022102517252562000_ehab773-B7","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.2013.282043","article-title":"Outcomes following transcatheter aortic valve replacement in the United States","volume":"310","author":"Mack","year":"2013","journal-title":"JAMA"},{"key":"2022102517252562000_ehab773-B8","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","article-title":"5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Mack","year":"2015","journal-title":"Lancet"},{"key":"2022102517252562000_ehab773-B9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"2022102517252562000_ehab773-B10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"key":"2022102517252562000_ehab773-B11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"2022102517252562000_ehab773-B12","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"2022102517252562000_ehab773-B13","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","article-title":"STS-ACC TVT Registry of transcatheter aortic valve replacement","volume":"76","author":"Carroll","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102517252562000_ehab773-B14","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jacc.2018.01.079","article-title":"Implementation of transcatheter aortic valve replacement in France","volume":"71","author":"Nguyen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102517252562000_ehab773-B15","author":"PMSI","year":"2012"},{"key":"2022102517252562000_ehab773-B16","author":"CCAM","year":"2012"},{"key":"2022102517252562000_ehab773-B17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"2022102517252562000_ehab773-B18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00392-016-1070-1","article-title":"Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair","volume":"106","author":"Gaede","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2022102517252562000_ehab773-B19","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa1500893","article-title":"Effect of availability of transcatheter aortic-valve replacement on clinical practice","volume":"373","author":"Reinohl","year":"2015","journal-title":"N Engl J Med"},{"key":"2022102517252562000_ehab773-B20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jacc.2018.04.077","article-title":"Development and in-hospital mortality of transcatheter and surgical aortic valve replacement in 2015 in Germany","volume":"72","author":"Stachon","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102517252562000_ehab773-B21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00392-020-01788-6","article-title":"Aortic valve replacement in Germany in 2019","volume":"110","author":"Gaede","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2022102517252562000_ehab773-B22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/eurheartj\/ehq261","article-title":"Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry","volume":"32","author":"Eltchaninoff","year":"2011","journal-title":"Eur Heart J"},{"key":"2022102517252562000_ehab773-B23","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa1114705","article-title":"Registry of transcatheter aortic-valve implantation in high-risk patients","volume":"366","author":"Gilard","year":"2012","journal-title":"N Engl J Med"},{"key":"2022102517252562000_ehab773-B24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jacc.2017.04.053","article-title":"Temporal trends in transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI","volume":"70","author":"Auffret","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102517252562000_ehab773-B25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jcin.2018.12.020","article-title":"The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3M TAVR study","volume":"12","author":"Wood","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102517252562000_ehab773-B26","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jacc.2019.07.014","article-title":"Management of conduction disturbances associated with transcatheter aortic valve replacement: JACC scientific expert panel","volume":"74","author":"Rodes-Cabau","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102517252562000_ehab773-B27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jacc.2016.11.033","article-title":"2016 annual report of the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter Valve Therapy Registry","volume":"69","author":"Grover","year":"2017","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/7\/666\/46630016\/ehab773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/7\/666\/46630016\/ehab773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T18:23:02Z","timestamp":1666722182000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/7\/666\/6439994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,11,25]]},"published-print":{"date-parts":[[2022,2,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab773","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,14]]},"published":{"date-parts":[[2021,11,25]]}}}